how much weight loss glp-1 Medication Program Mom Loses 65 Lbs With

And these anti-inflammatory effects dont require maximum doses

That finding changed how many providers think about long-term prescribing

8 The combination of high drug costs and a large patient population may have profound implications for employers overall health care spend

In the same study, Beyond the scale with Wegovy HD 1 Patients taking Wegovy HD pen 7.2 mg experienced improvements across most cardiometabolic risk factors Confirmatory secondary end points: Change from baseline to week 72 in 1 : Waist circumference: 5.6-inch reduction 2.2-inch reduction with placebo Supportive secondary end points: Change from baseline to week 72 in 1 : Lipid profile: Total cholesterol 3.4% reduction 4.0% reduction with placebo LDL 3.5% reduction 4.8% reduction with placebo HDL 9.5% increase 0.5% decrease with placebo Triglycerides 16.4% reduction 0.9% reduction with placebo Systolic blood pressure: 10.1 mm Hg reduction 4.8 mm Hg reduction with placebo Diastolic blood pressure: 4.5 mm Hg reduction 1.8 mm Hg reduction with placebo A1c: 0.3% reduction 0% change with placebo Safety end point: Change in 1 : Heart rate: 0.5 bpm increase 0.6 bpm reduction with placebo Wegovy is not indicated to treat hypertension, type 2 diabetes, or dyslipidemia